REQUEST A DEMO
Total
USD $0.00
Search more companies

Sirak Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sirak Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sirak Pharmaceuticals Private Limited is an unlisted company, incorporated on 08/01/2008. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24232TG2008PTC057045 and registration number is 057045. The company is a professional, scientific and technical company, it is engaged in scientific research and development.

Legal Address
Office No. 01B1 12A01B1, 12A (13Th) Floor, Manjeera Trinity Corporation, Jntu Rd, Kukatpally
Hyderabad; Telangana; Postal Code: 500072

Contact Details: Purchase the Sirak Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Sirak Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Sirak Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
January 08, 2008
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
49.87%
Company Performance
Financial values in the chart are available after Sirak Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
8.6%
Total operating revenue
-66.38%
Operating profit (EBIT)
-88.09%
EBITDA
-82%
Net Profit (Loss) for the Period
-89.56%
Total assets
9.74%
Total equity
5.21%
Operating Profit Margin (ROS)
-266.85%
Net Profit Margin
-220.09%
Return on Equity (ROE)
-44.97%
Debt to Equity Ratio
26.41%
Quick Ratio
-0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?